Updated:
Seibu Shinkin Capital
Seibu Shinkin Capital supports regional entrepreneurs, venture companies, and mid-sized and small enterprises. It leverages the history, know-how, and network...
Seibu Shinkin Capital
Seibu Shinkin Capital supports regional entrepreneurs, venture companies, and mid-sized and small enterprises. It leverages the history, know-how, and network of Seibu Shinkin Bank as a regional financial institution. Through investment and nurturing activities, it works on creating new industries and the sustainable development of the regional economy. Its business is the operation and management of investment partnership assets.
General information
Firm type
Generalist
Year founded
2003
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Principals
宇佐美 大典
代表取締役
Frequently asked questions
Does Seibu Shinkin Capital raise outside funds or invest solely from the parent bank's balance sheet?
All available evidence points to a balance-sheet investment model funded entirely by the parent credit union. The firm does not disclose any external limited partners, and no partnership announcements reference fundraising. This structure means Seibu Shinkin Capital does not face typical venture fund deployment timelines or return-of-capital obligations.
What investment stages does Seibu Shinkin Capital typically target?
The firm's disclosed mandate spans seed, startup, and growth stages through late-stage expansion. Its portfolio includes early-stage university spinouts and later-stage companies pursuing IPO on Japanese exchanges. The 20 IPOs it has supported confirm a strategy that holds positions through public listing.
Has Seibu Shinkin Capital disclosed the size of any individual investments?
No. The firm does not publish check-size ranges in yen or any other currency. Its investment announcements treat the financial terms as confidential, and regulatory filings in Japan do not require disclosure of specific amounts.
How many companies has Seibu Shinkin Capital taken public?
The firm reports 20 IPOs from its portfolio, with J-Pharma's listing on the Tokyo Stock Exchange Growth Market as the most recent. It highlights this track record prominently as a measure of its investment outcomes.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: